Use of Buccal Trypsin in Two Diabetics With the Nephrotic Syndrome

Neubauer, Richard A.; Esposito, John G.; Sindoni, Anthony

doi:10.1097/00000441-195905000-00002

Search citation statements

Order By: Relevance

Paper Sections

Select...

Adjunctive Use Of Other Agents1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1961

1977

Publication Types

Select...

Book3

Article2

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Large doses of this agent ( i.e. , 30 mg. daily) have been administered buccally to diabetics over a period of months without significant toxicity and with apparent amelioration of an associated nephrotic syndrome (110). Studies involving the supportive use of similar agents, including parenteral administration of chymotrypsin (Chymar, Aqueous) 2 and oral administration of chymotrypsin plus trypsin (Chymoral) 2 are in progress.…”

Section: Adjunctive Use Of Other Agentsmentioning

confidence: 99%